Right now, we actually have no plans to move forward; it’s ready to go if we decide,” company spokeswoman said.

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...

Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

An adult human body consists of some 37 trillion cells. Not so long ago, these were thought to come in 220 different types.

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

While the disease is of no concern in SA, work on the candidate shot is part of a strategy that is important to Africa, says CEO ...

Trump's pick for health secretary has a record of attacking vaccines. In fact he's even taken direct aim at bird flu shots.

Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine as concerns about a bird flu pandemic in humans ...

Beyond sidestepping people’s fear of needles, these vaccines would also make it easier to store and distribute ahead of ...